Insider Trading28 Sept 2026, 04:26 pm
Kabra Drugs Ltd Closes Trading Window for Q2 FY27 Results
AI Summary
Kabra Drugs Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ending September 30, 2026. The specific date for the board meeting to consider these results will be communicated separately.
Key Highlights
- Trading window closed from October 1, 2026.
- Closure is for unaudited financial results of Q2 FY27.
- Applies to designated persons and immediate relatives.
- Compliance with SEBI (Prohibition of Insider Trading) Regulations.
- Board meeting date for results to be announced later.
Price Impact
More from KABRADG